摘要
目的：研究阿奇霉素联合孟鲁司特治疗小儿肺炎支原体肺炎的临床疗效。方法：选取2010年2月-2012年2月在我院接受治疗的40例患支原体肺炎的患儿，将其随机分成两组，其中，对照组有20例，进行阿奇霉素的静脉滴注以及常规对症口服；治疗组20例，则在对照组的基础上再加以孟鲁司特进行口服，然后对两组患儿的治愈率和总有效率进行比较，并观察患儿不良反应、临床症状以及体征的消失时间。结果：治疗组患者的治愈率以及总有效率都明显比对照组高，P〈0．05。且治疗组患儿咳嗽、气喘以及肺部湿口罗音的消失时间都比对照组的少，P〈0．05；在整个治疗过程中，没有发现治疗组患儿和孟鲁司存在不良反应特征。结论：阿奇霉素联合孟鲁司特治疗小儿肺炎支原体肺炎，可以使支原体肺炎的患儿临床症状得到有效改善，且能缩短治疗时间，进而提高小儿肺炎支原体肺炎的治愈率。
Objective：Study on clinical effect of Azithromycin combined with montelukast in the treatment of children with mycoplasma pneumonia. Method： Select 40 cases of mycoplasma pneumonia in 2010 February to 2012 February in our hospital were children, were randomly divided into two groups, of which, 20 cases of the control group, intravenous drip of azithromycin and sequential oral; 20 cases in treatment group, on the basis of the control group plus with montelukast for oral administration. Result： The patients in the treatment group cure rate and total effective rate were significantly higher than those of the control group, P 〈 0.05. And the treat- ment group were cough. Conclusion： Azithromycin combined with montelukast in the treatment of children with mycoplasma pneumonia, the clinical symptoms in children with mycoplasma pneumonia can be effectively im- proved, and can shorten the treatment time, and improve the cure rate of Mycoplasma pneumoniae pneumonia in children.
出处
《内蒙古医学杂志》
2013年第6期658-659,共2页
Inner Mongolia Medical Journal
关键词
支原体肺炎
阿奇霉素
孟鲁司特
Primary atypical pneumonia
Azithromycin
Montelukast
